Compound ID | 2296
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus and Mycobacterium tuberculosis |
| Description: | Semisynthetic compound based on natural product from venom of scorpion Diplocentrus melici with with benzoquinone scaffold; non-cytotoxicity observed in lung adenocarcinoma cell line (cytotoxic to T-cell leukemia, rhabdomyosarcoma, and metastatic neuroblastoma cell lines); at >100 ug/ml no erythrocyte haemolysis |
| Institute where first reported: | Department of Molecular Medicine and Bioprocesses, Instituto de Biotecnologia, Universidad Nacional Autonoma de Mexico; Department of Chemistry, Stanford University, Stanford, CA; |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://www.pnas.org/doi/10.1073/pnas.1812334116 |
| Patent: | US2021214303A1 |